Conmana Combined With Thalidomide to Treat NSCLC

NCT02778893 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

67

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Conmana
DRUG: Thalidomide

Sponsor

Henan Provincial People's Hospital